We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Ventas (VTR - Free Report) to post quarterly earnings of $0.85 per share in its upcoming report, which indicates a year-over-year increase of 6.3%. Revenues are expected to be $1.37 billion, up 14.3% from the year-ago quarter.
The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Ventas metrics that are commonly tracked and projected by analysts on Wall Street.
The collective assessment of analysts points to an estimated 'Revenues- Rental income- Outpatient medical & research portfolio' of $222.56 million. The estimate points to a change of +1.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenues- Interest and other income' should come in at $2.98 million. The estimate indicates a change of -38.2% from the prior-year quarter.
Analysts predict that the 'Revenues- Resident fees and services' will reach $977.05 million. The estimate indicates a change of +19.5% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenues- Rental income- Triple-net leased' should arrive at $153.51 million. The estimate points to a change of -0.3% from the year-ago quarter.
The consensus among analysts is that 'Revenues- Third party capital management revenues' will reach $4.38 million. The estimate points to a change of +1.1% from the year-ago quarter.
Analysts' assessment points toward 'Depreciation and amortization' reaching $319.33 million.
Ventas shares have witnessed a change of +3.3% in the past month, in contrast to the Zacks S&P 500 composite's +3.6% move. With a Zacks Rank #3 (Hold), VTR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts expect Ventas (VTR - Free Report) to post quarterly earnings of $0.85 per share in its upcoming report, which indicates a year-over-year increase of 6.3%. Revenues are expected to be $1.37 billion, up 14.3% from the year-ago quarter.
The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Ventas metrics that are commonly tracked and projected by analysts on Wall Street.
The collective assessment of analysts points to an estimated 'Revenues- Rental income- Outpatient medical & research portfolio' of $222.56 million. The estimate points to a change of +1.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenues- Interest and other income' should come in at $2.98 million. The estimate indicates a change of -38.2% from the prior-year quarter.
Analysts predict that the 'Revenues- Resident fees and services' will reach $977.05 million. The estimate indicates a change of +19.5% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenues- Rental income- Triple-net leased' should arrive at $153.51 million. The estimate points to a change of -0.3% from the year-ago quarter.
The consensus among analysts is that 'Revenues- Third party capital management revenues' will reach $4.38 million. The estimate points to a change of +1.1% from the year-ago quarter.
Analysts' assessment points toward 'Depreciation and amortization' reaching $319.33 million.
View all Key Company Metrics for Ventas here>>>Ventas shares have witnessed a change of +3.3% in the past month, in contrast to the Zacks S&P 500 composite's +3.6% move. With a Zacks Rank #3 (Hold), VTR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .